申请人:Cassella Aktiengesellschaft
公开号:US05079244A1
公开(公告)日:1992-01-07
Substituted 3-aminosydnone imines of the general formula I ##STR1## and their pharmacologically acceptable acid addition salts, in which A denotes an alkylene chain; X denotes one of the groups --O-- or --S--; R.sup.1 denotes e.g. hydrogen; R.sup.2 denotes e.g. an alkyl group, are prepared by cyclization of a compound of the formula II ##STR2## and, if appropriate, subsequent acylation, and have useful pharmacological properties.
通式I中的3-氨基氧代硫代酮亚胺及其药理学可接受的酸盐,其中A代表一个烷基链;X代表--O--或--S--中的一个基团;R.sup.1代表例如氢原子;R.sup.2代表例如一个烷基团,通过将通式II的化合物环化制备,如果必要,随后进行酰化,具有有用的药理学性质。